LYON, France & MIDDLETON, Wis.–(BUSINESS WIRE)–Esker today announced that Optic 2000, a leading optical retailer in France, is automating its procure-to-pay (P2P) processes with Esker.
Author: Business Wire
SoftServe Acknowledged as a Major Contender in Healthcare Analytics Services by Everest Group
AUSTIN, Texas–(BUSINESS WIRE)– #MajorContender–SOFTSERVE ACKNOWLEDGED AS A MAJOR CONTENDER IN HEALTHCARE ANALYTICS SERVICES BY EVEREST GROUP
Aerie Concludes Exclusive License Agreement With Santen for Rhopressa® and Rocklatan® in Europe and Several Other Regions
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”) announced that Aerie and Santen have entered into an exclusive development and commercialization agreement for Rhopressa®/Rhokiinsa® (netarsudil ophthalmic solution) 0.0…
Gyroscope Therapeutics Announces Appointment of Tony Adamis to Board of Directors
LONDON–(BUSINESS WIRE)–Gyroscope Therapeutics announces appointment of Tony Adamis to Board of Directors.
Brazil Electronic Medical Record Markets Report 2021: Licensed Software, Technology Resale, Subscriptions, Professional Services – Forecast to 2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Brazil Electronic Medical Record Market – Forecasts from 2021 to 2026” report has been added to ResearchAndMarkets.com’s offering. Brazil Electronic Medical Record market is projected to grow at a CAGR of 8.33% to reach US…
Ocular Therapeutix™ Announces Topline Results for Phase 2 Clinical Trial of OTX-DED for the Short-Term Treatment of Dry Eye Disease
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
ABIONYX Pharma Announces the Completion of a Contribution in Kind to the Company of 100% of the Capital of IRIS Pharma Holding, Fully Compensated by the Issue of New Shares at a Price of €3.60 Per Share to Become a Specialist of Bioproducts…
TOULOUSE, France–(BUSINESS WIRE)– ABIONYX Pharma Announces the Completion of a Contribution in Kind to the Company of 100% of the Capital of IRIS Pharma Holding, Fully Compensated by the Issue of New Shares at a Price of €3.60 Per Share to Become a …
Global Wet (Neovascular / Exudative) Macular Degeneration Clinical Trials Market Review, H2 2021 Report – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Wet (Neovascular / Exudative) Macular Degeneration – Global Clinical Trials Review, H2, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. The report provides an overview of Wet (Neovascular / Exuda…
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK–(BUSINESS WIRE)–Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to six newly-hired, non-executive employees.
Heru Selected to Present Among Titans in Healthcare, Medicine, Science and Business at the 10th Annual Forbes Healthcare Summit
MIAMI–(BUSINESS WIRE)–Mohamed Abou Shousha, MD, PhD, founder and CEO of vision diagnostics and augmentation leader Heru Inc., is among the titans in the industry that have been hand-selected to present virtually this afternoon at the 10th Annual Forb…
Omeros Announces Agreement to Sell OMIDRIA® Franchise to Rayner Surgical in a Transaction Valued in Excess of $1 Billion
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) today announced that it has entered into a definitive agreement for the sale of OMIDRIA to Rayner Surgical Group Limited. Expected to close on or before December 31, 2021, the transaction incl…
Global Diabetes Associated Ophthalmic Treatment Market Report 2021-2028: Focus on Dry Eye, Glaucoma, Diabetic Retinopathy, DAMD, Uveitis, Cataract – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Diabetes Associated Ophthalmic Treatment Market 2021-2028” report has been added to ResearchAndMarkets.com’s offering. The global diabetes associated ophthalmic treatment market size is expected to reach USD 44.7 billion b…
Seoul Semiconductor fornisce LED SunLike, basati su una tecnologia di riproduzione della luce naturale, per i sistemi di illuminazione per lo studio di KOIZUMI
ANSAN, Corea del Sud–(BUSINESS WIRE)–Seoul Semiconductor Co., Ltd. (KOSDAQ: 046890), società di portata globale produttrice di semiconduttori ottici, ha annunciato lo scorso 2 novembre di avere fornito i LED SunLike a luce naturale all’azienda giappo…
Seoul Semiconductor Supplies SunLike LED, a Natural Light Reproduction Technology, to KOIZUMI's Learning Lighting
ANSAN, South Korea–(BUSINESS WIRE)– #DeskLamp–Seoul Semiconductor supplies SunLike LED, a natural light reproduction technology, to KOIZUMI’s desk light to create an optimal learning environment.
Seoul Semiconductor fournit SunLike LED, technologie de reproduction de la lumière naturelle, pour les lampes de bureau de KOIZUMI
ANSAN, Corée du Sud–(BUSINESS WIRE)–Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), société mondiale de semi-conducteurs optiques, a annoncé le 2 avoir fourni SunLike, une LED à lumière naturelle, à KOIZUMI FURNITECH Technology Corp., société japonais…
Seoul Semiconductor liefert SunLike LED, eine Technologie zur Reproduktion von natürlichem Licht, an die Firma KOIZUMI's Learning Lighting
ANSAN, Südkorea–(BUSINESS WIRE)–Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), ein weltweit operierendes Unternehmen für optische Halbleiter, gab am 2. Mai bekannt, dass es SunLike, eine LED mit natürlichem Licht, an KOIZUMI FURNITECH Technology Corp…
ソウル半導体、コイズミ学習照明に自然光再現技術「サンライク」LEDを供給
韓国安山市–(BUSINESS WIRE)–（ビジネスワイヤ） — 世界的なLED (発光ダイオード)専業メーカーのSeoul Semiconductor Co., Ltd. (本社：韓国安山市、代表理事：李貞勲、以下「ソウル半導体」)は、 自然光LED「サンライク(SunLike)」技術を、日本の学習家具メーカーのコイズミファニテック社 （KOIZUMI FURNITECH Corp.）に供給したと2日、明らかにした。 コイズミファニテック社は、プレミアム照明会社であるコイズミ照明と同じく、…
Global Central Retinal Vein Occlusion Clinical Trials Market Research Report, H2 2021 Review – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Central Retinal Vein Occlusion – Global Clinical Trials Review, H2, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. The clinical trial report provides an overview of Central Retinal Vein Occlusio…
Trefoil Therapeutics Announces Third Tranche of $28 Million Series A Financing Based on Achievement of Clinical Trial Objectives
SAN DIEGO–(BUSINESS WIRE)–Trefoil therapeutics announces third tranche of $28 million Series A financing based on achievement of clinical objectives
National Vision Investor Relations Named to Institutional Investor’s 2022 All-America Executive Team
DULUTH, Ga.–(BUSINESS WIRE)– #eyecare–National Vision Holdings, Inc. (NASDAQ: EYE), the nation’s second largest optical retailer, announced that its investor relations leadership have been named to Institutional Investor’s 2022 All-America Executive…